News in the Life Sciences Industry

LUND, Sweden, Sept. 2, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia") a near-commercial stage diagnostics company developing ground-breaking antibody-based multiplex microarray technology platform called IMMray(TM) for the early detection of cancer, announced today that Dr. Peter Schultz-Knappe,... Read more ››

LUND, Sweden, Sept. 1, 2020 /PRNewswire/ -- Hansa Biopharma ("Hansa"), the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced updated guidance regarding its ongong and planned clinical trial program ahead of Management's participation at upcoming investor... Read more ››

UPPLANDS VASBY, Sweden, Sept. 1, 2020 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that they are expanding their network of stations by adding Beijing (PEK), China, to the growing list of e-technology... Read more ››

GOTHENBURG, Sweden, Sept. 1, 2020 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), has announced today that the company has further strengthened its position in the second largest market for treatment of mCRC by obtaining two new patent grants... Read more ››

COPENHAGEN, Denmark, Sept. 1, 2020 /CNW/ -- In a new investment round, Visiopharm added BankInvest to the group of institutional investors that already includes ATP, NorthCap, Vækstfonden, and C.L. Davids Fond. BankInvest now holds almost 6% of the equity of the company. All existing investors... Read more ››

COPENHAGEN, Denmark, Aug. 31, 2020 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced headline results from the parallel group, double-blind, randomized, placebo-controlled RELIEF studyRead more ››

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE... Read more ››